Cargando…

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock

BACKGROUND: Only a few observational studies using small patient samples and one subgroup analysis have compared norepinephrine and dopamine for the treatment of cardiogenic shock (CS). The objective of the present study was to investigate whether the use of norepinephrine was associated with improv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Soo Jin, Yang, Jeong Hoon, Ko, Ryoung-Eun, Chung, Chi Ryang, Cho, Yang Hyun, Choi, Ki Hong, Kim, Darae, Park, Taek Kyu, Lee, Joo Myung, Song, Young Bin, Choi, Jin-Oh, Hahn, Joo-Yong, Choi, Seung-Hyuk, Gwon, Hyeon-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632770/ https://www.ncbi.nlm.nih.gov/pubmed/36327286 http://dx.doi.org/10.1371/journal.pone.0277087

Ejemplares similares

Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock
por: Park, Taek Kyu, et al.
Publicado: (2014)

Clinical Outcomes of Patients with Acute Myocardial Infarction Complicated by Severe Refractory Cardiogenic Shock Assisted with Percutaneous Cardiopulmonary Support
por: Park, Taek Kyu, et al.
Publicado: (2014)

External validation and comparison of two delirium prediction models in patients admitted to the cardiac intensive care unit
por: Kim, Sung Eun, et al.
Publicado: (2022)

Impact of the Obesity Paradox Between Sexes on In‐Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study
por: Kwon, Woochan, et al.
Publicado: (2022)

Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock
por: Yang, Jeong Hoon, et al.
Publicado: (2013)

Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis
por: Rui, Qing, et al.
Publicado: (2017)

State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023)

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
por: Sharma, Vinay K, et al.
Publicado: (2003)

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine
por: Vincent, Jean-Louis, et al.
Publicado: (2003)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
por: Lee, Joo Myung, et al.
Publicado: (2019)

Culprit‐Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial‐Extracorporeal Membrane Oxygenation
por: Choi, Ki Hong, et al.
Publicado: (2023)

Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock
por: Park, Ik Hyun, et al.
Publicado: (2023)

Renal effect of dopamine, norepinephrine, epinephrine, or norepinephrine–dobutamine in septic shock
por: Qiu, HB, et al.
Publicado: (2002)

Prognostic Value of Admission Blood Glucose Level in Critically Ill Patients Admitted to Cardiac Intensive Care Unit according to the Presence or Absence of Diabetes Mellitus
por: Kim, Sua, et al.
Publicado: (2019)

Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study
por: Kim, So Ree, et al.
Publicado: (2019)

Use of intravascular ultrasound and long-term cardiac death or myocardial infarction in patients receiving current generation drug-eluting stents
por: Lee, Sang Yoon, et al.
Publicado: (2022)

Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test
por: Kim, Jihoon, et al.
Publicado: (2019)

Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fraction
por: Seo, Jeong Hun, et al.
Publicado: (2022)

Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenation
por: Hong, David, et al.
Publicado: (2020)

Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era
por: Cho, Sung Woo, et al.
Publicado: (2020)

Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10‐Year Follow‐Up Study
por: Park, Taek Kyu, et al.
Publicado: (2021)

Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction
por: Choi, Ki Hong, et al.
Publicado: (2023)

Real-life use of vasopressors and inotropes in cardiogenic shock—observation is necessarily ‘theory-laden’
por: Ray, Samiran, et al.
Publicado: (2016)

Norepinephrine: more of a neurohormone than a vasopressor
por: Myburgh, John
Publicado: (2010)

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017)

Clinical Implications of Thrombocytopenia at Cardiogenic Shock Presentation: Data from a Multicenter Registry
por: Lee, Hyeok-Hee, et al.
Publicado: (2020)

Is norepinephrine more effective than other vasopressors for septic shock? A systematic review and meta-analysis
por: Zhou, F, et al.
Publicado: (2013)

Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis
por: Sedhai, Yub Raj, et al.
Publicado: (2022)

The association of findings on brain computed tomography with neurologic outcomes following extracorporeal cardiopulmonary resuscitation
por: Ryu, Jeong-Am, et al.
Publicado: (2017)

Comparative study of dopamine and norepinephrine in the management of septic shock
por: Agrawal, Avinash, et al.
Publicado: (2011)

Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina
por: Gwag, Hye Bin, et al.
Publicado: (2017)

Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality
por: Lu, Xin, et al.
Publicado: (2022)

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Shin, Eun-Seok, et al.
Publicado: (2023)

The Proximal Optimization Technique Improves Clinical Outcomes When Treated without Kissing Ballooning in Patients with a Bifurcation Lesion
por: Yang, Jeong Hoon, et al.
Publicado: (2019)

Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug‐Eluting Stent Era
por: Kim, Jihoon, et al.
Publicado: (2018)

Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Karami, Mina, et al.
Publicado: (2020)

Dopamine versus norepinephrine in septic shock: a meta-analysis
por: Shenoy, S, et al.
Publicado: (2011)

Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock
por: Jain, Gaurav, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cvkjjvtgndloagjh7budveqv6h